Document Detail


Clinical features of paediatric pulmonary hypertension: a registry study.
MedLine Citation:
PMID:  22240409     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Paediatric pulmonary hypertension, is an important cause of morbidity and mortality, and is insufficiently characterised in children. The Tracking Outcomes and Practice in Pediatric Pulmonary Hypertension (TOPP) registry is a global, prospective study designed to provide information about demographics, treatment, and outcomes in paediatric pulmonary hypertension.
METHODS: Consecutive patients aged 18 years or younger at diagnosis with pulmonary hypertension and increased pulmonary vascular resistance were enrolled in TOPP at 31 centres in 19 countries from Jan 31, 2008, to Feb 15, 2010. Patient and disease characteristics, including age at diagnosis and at enrolment, sex, ethnicity, presenting symptoms, pulmonary hypertension classification, comorbid disorders, medical and family history, haemodynamic indices, and functional class were recorded. Follow-up was decided by the patients' physicians according to the individual's health-care needs.
FINDINGS: 362 of 456 consecutive patients had confirmed pulmonary hypertension (defined as mean pulmonary artery pressure ≥25 mm Hg, pulmonary capillary wedge pressure ≤12 mm Hg, and pulmonary vascular resistance index ≥3 WU/m(-2)). 317 (88%) patients had pulmonary arterial hypertension (PAH), which was idiopathic [IPAH] or familial [FPAH] in 182 (57%), and associated with other disorders in 135 (43%), of which 115 (85%) cases were associated with congenital heart disease. 42 patients (12%) had pulmonary hypertension associated with respiratory disease or hypoxaemia, with bronchopulmonary dysplasia most frequent. Finally, only three patients had either chronic thromboembolic pulmonary hypertension or miscellaneous causes of pulmonary hypertension. Chromosomal anomalies, mainly trisomy 21, were reported in 47 (13%) of patients with confirmed disease. Median age at diagnosis was 7 years (IQR 3-12); 59% (268 of 456) were female. Although dyspnoea and fatigue were the most frequent symptoms, syncope occurred in 31% (57 of 182) of patients with IPAH or FPAH and in 18% (eight of 45) of those with repaired congenital heart disease; no children with unrepaired congenital systemic-to-pulmonary shunts had syncope. Despite severe pulmonary hypertension, functional class was I or II in 230 of 362 (64%) patients, which is consistent with preserved right-heart function.
INTERPRETATION: TOPP identifies important clinical features specific to the care of paediatric pulmonary hypertension, which draw attention to the need for paediatric data rather than extrapolation from adult studies.
FUNDING: Actelion Pharmaceuticals.
Authors:
Rolf M F Berger; Maurice Beghetti; Tilman Humpl; Gary E Raskob; D Dunbar Ivy; Zhi-Cheng Jing; Damien Bonnet; Ingram Schulze-Neick; Robyn J Barst
Related Documents :
19161799 - Fabry disease with aortic regurgitation.
307089 - Aortic valve replacement and aorta-coronary bypass surgery. results with perfusion of p...
8800699 - Cryopreserved arterial homografts for in situ reconstruction of mycotic aneurysms and p...
8470439 - Association of aortic stenosis and gastrointestinal bleeding (heyde's syndrome). report...
22130819 - Looking to the future: a new decade of pulmonary arterial hypertension therapy.
18456709 - Valve failure following homograft aortic valve replacement: does implantation technique...
23094509 - Detailed observation of arterial healing after stent implantation in swine arteries by ...
3885419 - Current status of surgery for congenital heart disease in infancy.
12792859 - Combination therapy in treatment of experimental pulmonary aspergillosis: synergistic i...
Publication Detail:
Type:  Journal Article; Multicenter Study     Date:  2012-01-11
Journal Detail:
Title:  Lancet     Volume:  379     ISSN:  1474-547X     ISO Abbreviation:  Lancet     Publication Date:  2012 Feb 
Date Detail:
Created Date:  2012-02-13     Completed Date:  2012-02-21     Revised Date:  2013-06-26    
Medline Journal Info:
Nlm Unique ID:  2985213R     Medline TA:  Lancet     Country:  England    
Other Details:
Languages:  eng     Pagination:  537-46     Citation Subset:  AIM; IM    
Copyright Information:
Copyright © 2012 Elsevier Ltd. All rights reserved.
Affiliation:
Centre for Congenital Heart Diseases-Paediatric Cardiology, Beatrix Children's Hospital, University Medical Centre Groningen, University of Groningen, Netherlands. r.m.f.berger@umcg.nl
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Age of Onset
Cardiac Catheterization
Child
Child, Preschool
Female
Humans
Hypertension, Pulmonary / diagnosis*,  etiology,  physiopathology
Infant
Male
Registries
Vascular Resistance
Grant Support
ID/Acronym/Agency:
UL1 RR025780/RR/NCRR NIH HHS
Comments/Corrections
Comment In:
Lancet. 2012 Feb 11;379(9815):500-1   [PMID:  22240410 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Single-dose azithromycin versus benzathine benzylpenicillin for treatment of yaws in children in Pap...
Next Document:  Efficacy and mechanism of action of arachidonic acid in the treatment of hamsters infected with Schi...